Monday, 23 May 2005 - 10:45 AM

This presentation is part of: Strategies for Growth: How a “Small” Company can become a “Big” Player

Attracting Investment from Large Pharma

Todd Burns, Johnson & Johnson, New Brunswick, NJ

One means by which start-ups obtain funding is through equity investments made by large pharmaceutical corporations. This talk will focus on equity investing by Johnson & Johnson (J&J) and the factors J&J considers when deciding whether to invest in a start-up company. Specific topics to be addressed include the process of obtaining equity investments, a brief review of the mechanics of such investments and what steps a company could and should take to make its business an attractive target for equity investments. Obviously a significant factor that J&J considers when reviewing smaller companies for potential investments are barriers to entry, including IP. The second part of the presentation will examine the ways a company can improve its IP position to become more attractive to a larger company.

Back to Strategies for Growth: How a “Small” Company can become a “Big” Player
Back to The 37th Middle Atlantic Regional Meeting (May 22-25, 2005)